Latest Insider Transactions at Syneos Health, Inc. (SYNH)
This section provides a real-time view of insider transactions for Syneos Health, Inc. (SYNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syneos Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syneos Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
362
-5.73%
|
$29,322
$81.0 P/Share
|
|
Feb 16
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,450
-5.93%
|
$971,100
$78.59 P/Share
|
|
Feb 16
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,475
-5.02%
|
$271,050
$78.59 P/Share
|
|
Feb 02
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
278
-0.13%
|
$21,406
$77.11 P/Share
|
|
Feb 01
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Bona fide gift
|
Direct |
750
-2.76%
|
-
|
|
Feb 01
2021
|
Paul Colvin Pres., Clinical Solutions |
SELL
Open market or private sale
|
Direct |
8,486
-23.08%
|
$627,964
$74.82 P/Share
|
|
Feb 01
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,219
-12.16%
|
$4,816,425
$75.5 P/Share
|
|
Jan 25
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.14%
|
$300,000
$75.68 P/Share
|
|
Jan 25
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Open market or private sale
|
Direct |
5,336
-16.39%
|
$400,200
$75.68 P/Share
|
|
Jan 17
2021
|
Robert Parks EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-3.58%
|
$31,185
$77.13 P/Share
|
|
Jan 15
2021
|
Paul Colvin Pres., Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
11,463
+23.77%
|
-
|
|
Jan 15
2021
|
Paul Colvin Pres., Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-6.53%
|
$132,600
$75.42 P/Share
|
|
Jan 15
2021
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,463
+16.98%
|
-
|
|
Jan 15
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,720
-3.71%
|
$129,000
$75.42 P/Share
|
|
Jan 15
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,148
+14.66%
|
-
|
|
Jan 15
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,641
-3.25%
|
$573,075
$75.42 P/Share
|
|
Jan 15
2021
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,344
+16.17%
|
-
|
|
Jan 15
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,367
-2.39%
|
$102,525
$75.42 P/Share
|
|
Jan 15
2021
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
8,492
+20.69%
|
-
|
|
Jan 15
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-4.16%
|
$78,225
$75.42 P/Share
|
|
Jan 08
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-6.08%
|
$118,625
$73.59 P/Share
|
|
Jan 08
2021
|
Robert Parks EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-5.66%
|
$49,567
$73.59 P/Share
|
|
Jan 08
2021
|
Paul Colvin Pres., Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
2,031
-6.98%
|
$148,263
$73.59 P/Share
|
|
Jan 08
2021
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,103
-4.34%
|
$153,519
$73.59 P/Share
|
|
Jan 08
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,154
-4.14%
|
$741,242
$73.59 P/Share
|
|
Jan 08
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,732
-2.94%
|
$126,436
$73.59 P/Share
|
|
Jan 06
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,552
-8.61%
|
$399,744
$72.0 P/Share
|
|
Jan 02
2021
|
Paul Colvin Pres., Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-0.85%
|
$16,683
$67.36 P/Share
|
|
Dec 23
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300
-0.12%
|
$21,000
$70.52 P/Share
|
|
Dec 22
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
1,500
-2.27%
|
-
|
|
Dec 22
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,200
-0.49%
|
$84,000
$70.02 P/Share
|
|
Dec 03
2020
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
19,369,446
-17.31%
|
$1,181,536,206
$61.28 P/Share
|
|
Dec 03
2020
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
1,254
-17.31%
|
$76,494
$61.28 P/Share
|
|
Dec 03
2020
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
5,542,264
-17.31%
|
$338,078,104
$61.28 P/Share
|
|
Dec 03
2020
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
3,228,241
-17.31%
|
$196,922,701
$61.28 P/Share
|
|
Dec 03
2020
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
3,228,241
-17.31%
|
$196,922,701
$61.28 P/Share
|
|
Dec 03
2020
|
Robert Parks EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
660
-5.22%
|
$40,920
$62.62 P/Share
|
|
Dec 01
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-0.96%
|
$30,550
$65.72 P/Share
|
|
Nov 27
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,062
-5.8%
|
$272,154
$67.0 P/Share
|
|
Nov 24
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,938
-2.69%
|
$129,846
$67.0 P/Share
|
|
Nov 18
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
856
-1.72%
|
$55,640
$65.0 P/Share
|
|
Nov 17
2020
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94
+0.19%
|
$4,982
$53.64 P/Share
|
|
Nov 17
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
800
-1.59%
|
$49,600
$62.65 P/Share
|
|
Nov 13
2020
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,104
-3.97%
|
$69,552
$63.25 P/Share
|
|
Nov 01
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.05%
|
$1,925
$55.95 P/Share
|
|
Sep 17
2020
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Direct |
1,464
-16.8%
|
$86,376
$59.26 P/Share
|
|
Sep 17
2020
|
Thomas H. Lee Advisors, LLC |
SELL
Open market or private sale
|
Indirect |
6,465,974
-16.8%
|
$381,492,466
$59.26 P/Share
|
|
Sep 17
2020
|
Advent International Corp |
SELL
Open market or private sale
|
Indirect |
22,597,686
-16.8%
|
$1,333,263,474
$59.26 P/Share
|
|
Sep 17
2020
|
John L. Maldonado |
SELL
Open market or private sale
|
Indirect |
3,766,281
-16.8%
|
$222,210,579
$59.26 P/Share
|
|
Sep 17
2020
|
Tom Allen |
SELL
Open market or private sale
|
Indirect |
3,766,281
-16.8%
|
$222,210,579
$59.26 P/Share
|